Integra LifeSciences Schedules Conference Call for Wednesday, July 28 to Discuss Second Quarter 2004 Financial Results and Update Forward-Looking Financial Guidance
PLAINSBORO, N.J.--(BUSINESS WIRE)--July 14, 2004--Integra LifeSciences Holdings Corporation (Nasdaq:IART) has scheduled a conference call for 9:00 AM EDT on Wednesday, July 28 to discuss financial results for the second quarter ended June 30, 2004 and to update forward-looking financial guidance. Financial results for the second quarter 2004 will be announced via a news release issued after the market closes on July 27.
The conference call will be hosted by Stuart Essig, President and Chief Executive Officer of Integra, and will be open to all listeners. Additional forward-looking information may be discussed in a question and answer session following the call.
Access to the live call is available by dialing 973-582-2732 or through a webcast via a link provided on Integra's website at www.Integra-LS.com. Access to a replay is available through August 11, 2004 by dialing 973-341-3080 (PIN 4865967) or through the webcast.
Integra LifeSciences Holdings Corporation is a diversified medical technology company that develops, manufactures, and markets medical devices for use in a variety of applications. The primary applications for Integra's products are neuro-trauma and neurosurgery, plastic and reconstructive surgery and general surgery. Integra is a leader in applying the principles of biotechnology to medical devices that improve patients' quality of life. Our corporate headquarters are in Plainsboro, New Jersey, and we have manufacturing and research facilities located throughout the world.
CONTACT: Integra LifeSciences Holdings Corporation
John Bostjancic, 609-936-2239
jbostjancic@integra-ls.com
or
Maria Platsis, 609-936-2333
mplatsis@integra-ls.com
SOURCE: Integra LifeSciences Holdings Corporation